Trial of Maintenance With Niraparib- Uterine Serous Carcinoma
Public ClinicalTrials.gov record NCT04080284. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Trial of Maintenance With Niraparib in Patients With Stage III, Stage IV or Platinum-sensitive Recurrent Uterine Serous Carcinoma
Study identification
- NCT ID
- NCT04080284
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Northwell Health
- Other
- Enrollment
- 22 participants
Conditions and interventions
Conditions
Interventions
- Niraparib Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 29, 2019
- Primary completion
- Dec 31, 2024
- Completion
- Dec 31, 2024
- Last update posted
- Aug 18, 2025
2019 – 2025
United States locations
- U.S. sites
- 6
- U.S. states
- 2
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Rutgers Cancer Institute of New Jersey | New Brunswick | New Jersey | 07103 | — |
| Rutgers NJ School of Medicine | Newark | New Jersey | 07103 | — |
| Imbert Cancer Center Northwell Health | Bay Shore | New York | 11706 | — |
| Greenlawn Cancer Institute, Northwell Health | Greenlawn | New York | 11740 | — |
| RJ Zuckerberg Cancer Hospital | New Hyde Park | New York | 11042 | — |
| Cancer Institute at Lenox Hill | New York | New York | 10075 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04080284, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 18, 2025 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04080284 live on ClinicalTrials.gov.